Antibiotice S.A. Announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was RON 242.409 million compared to RON 241.251 million a year ago. Operating income was RON 27.583 million compared to RON 24.782 million a year ago. Net income was RON 21.561 million compared to RON 21.173 million a year ago. Basic earnings per share was RON 0.032117 compared to RON 0.031539 a year ago.